| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Glutamyltransferase in Transgenic Mice Accelerates Bone Resorption and Causes OsteoporosisDepartment of Bone and Joint Disease (K.H., Y.A., S.Tak., S.Tat., N.K., S.N., K.I.) Research Institute, National Center for Geriatrics and Gerontology (NCGG), Obu, Aichi 474-8522, Japan; Department of Surgery (K.H., Y.A., Y.N.), Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan; National Institute of Biomedical Innovation (S.Tat.), Osaka 567-0085, Japan; Department of Genome Science (T.N.), Institute of Medical Science, St. Marianna University of Medicine, Kanagawa 216-8512, Japan; Department of Orthopedic Surgery (S.Tan.), University of Tokyo School of Medicine, Tokyo 113-8655, Japan; Department of Radiology (M.I.), Nagasaki University School of Medicine, Nagasaki 852-8501, Japan; and Department of Genetics and Development (G.K.), Columbia University, New York, New York 10032
Address all correspondence and requests for reprints to: Kyoji Ikeda, M.D., at Department of Bone and Joint Disease, Research Institute, National Center for Geriatrics and Gerontology (NCGG), 36-3 Gengo, Morioka, Obu, Aichi 474-8522, Japan. E-mail: kikeda{at}nils.go.jp.
We previously identified
-glutamyltransferase (GGT) by expression cloning as a factor inducing osteoclast formation in vitro. To examine its pathogenic role in vivo, we generated transgenic mice that overexpressed GGT in a tissue-specific manner utilizing the Cre-loxP recombination system. Systemic as well as local production of GGT accelerated osteoclast development and bone resorption in vivo by increasing the sensitivity of bone marrow macrophages to receptor activator of nuclear factor-
B ligand, an essential cytokine for osteoclastogenesis. Mutated GGT devoid of enzyme activity was as potent as the wild-type molecule in inducing osteoclast formation, suggesting that GGT acts not as an enzyme but as a cytokine. Recombinant GGT protein increased receptor activator of nuclear factor-
B ligand expression in marrow stromal cells and also stimulated osteoclastogenesis from bone marrow macrophages at lower concentrations. Thus, GGT is implicated as being involved in diseases characterized by accelerated osteoclast development and bone destruction and provides a new target for therapeutic intervention.
This article has been cited by other articles:
![]() |
K. A. Johnson, W. Yao, N. E. Lane, P. Naquet, and R. A. Terkeltaub Vanin-1 Pantetheinase Drives Increased Chondrogenic Potential of Mesenchymal Precursors in ank/ank Mice Am. J. Pathol., February 1, 2008; 172(2): 440 - 453. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |